Connect Biopharmaceuticals Funding: $195M Raised, Series C
Connect Biopharmaceuticals is based in Suzhou, China. It has raised $195M in total funding. Latest round: Series C.
Connect Biopharmaceuticals funding overview
Connect Biopharmaceuticals is based in Suzhou, China. Connect Biopharmaceuticals has raised $195M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in August 2020. The round record for Connect Biopharmaceuticals runs through 2020; nothing later has been disclosed. Investors on record include RA Capital Management, Boxer Capital, HBM Healthcare Investment, Lilly Asia Ventures, Qiming Venture Partners. 5 distinct backers are named across the disclosed rounds.
Connect Biopharmaceuticals at a glance
Total raised
$195M
Latest round
Series C
Latest round date
August 2020
Headquarters
Suzhou, China
Notable investors
RA Capital Management, Boxer Capital, HBM Healthcare Investment, Lilly Asia Ventures, Qiming Venture Partners
Frequently asked about Connect Biopharmaceuticals funding
How much has Connect Biopharmaceuticals raised?
Connect Biopharmaceuticals has raised $195M in total disclosed funding across the rounds on record.
Who has invested in Connect Biopharmaceuticals?
RA Capital Management, Boxer Capital, HBM Healthcare Investment, Lilly Asia Ventures, Qiming Venture Partners are named among the investors backing Connect Biopharmaceuticals.
What was the latest Connect Biopharmaceuticals funding round?
The most recent disclosed round is a Series C, announced in August 2020.
Where is Connect Biopharmaceuticals based?
Connect Biopharmaceuticals is based in Suzhou, China.
When did Connect Biopharmaceuticals last raise?
The last disclosed Connect Biopharmaceuticals round closed in August 2020 at Series C.
Every Connect Biopharmaceuticals figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Suzhou at a similar stage.
Companies related to Connect Biopharmaceuticals (36)
